Subjects were randomized to receive five weekly injections of 0.05, 0.3, 1, 3, 5 or 8 mg of dulaglutide. At the end of 5 weeks, reductions in FPG were significant (p < 0.05) at all doses except 0. ...

Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...

The UK’s medicines regulator has received over 100 reports of deaths potentially associated with widely used weight loss ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to ...

Weight-loss surgery significantly reduces the risk of psychiatric issues like cognitive decline, anxiety, and substance use ...

Long-acting (LA) glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) that require injection once a week ... semaglutide, dulaglutide and ITCA650. Published and preliminary data have shown ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Experts and organizations call for stricter regulations on how such medications are prescribed – Side effect reports under ...

Depending on the specific medication and its form, DMTs may be given orally, by injection, or by infusion. While many injectable DMTs may be self-injected at home, intravenous (IV) and infusion ...

Bariatric surgery shows better real-life results than GLP-1s in a study: the scalpel achieves five times more weight loss ...

Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and ...

The new oral drug is viewed as a key product for Novo Nordisk as it tries to case Eli Lilly's Trulicity (dulaglutide), a once-weekly GLP-1 drug that is the market leader in the class with sales of ...